Recombinant Human CDK14 Protein，His

CDK14 (cyclin-dependent kinase 14) is a relatively understudied member of the cyclin-dependent kinase family, which plays a crucial role in cell cycle regulation and transcriptional control. Recent research has highlighted its involvement in key cellular processes, including RNA splicing, transcriptional regulation, and cell proliferation, making it a protein of significant interest in cancer biology and other diseases. CDK14 functions through its association with cyclins, particularly cyclin Y, forming an active complex that influences the activity of various substrates, including RNA polymerase II. Aberrant expression and activity of CDK14 have been linked to oncogenic transformation and tumor progression, suggesting that it may serve as a potential therapeutic target. Additionally, the understanding of CDK14's mechanisms of action and its interaction with other cellular pathways can offer insights into the development of novel treatment strategies. To study CDK14's role in cellular processes, researchers have focused on the use of recombinant CDK14 protein, allowing for detailed biochemical analyses and functional assays. The generation of a high-purity, active form of CDK14 provides a platform for investigating its catalytic functions, substrate specificity, and regulatory mechanisms. Such studies aim to elucidate the intricacies of CDK14's role in cell cycle regulation and its impact on tumorigenesis, paving the way toward targeted therapies that may inhibit its activity in cancer cells, ultimately contributing to the development of more effective cancer treatments.